Bayer buys BlueRock Therapeutics, marks stance cell therapy space
Category: #health  By Mateen Dalal  Date: 2019-08-10
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Bayer buys BlueRock Therapeutics, marks stance cell therapy space
  • Versant Ventures’ portfolio company, Bluerock Therapeutics acquired by Bayer AG for approximately USD 1 billion.
  • This acquisition represents Versant’s robust progress in the region of Canada.

California headquartered Versant Ventures reportedly announced the acquisition of its cell therapy company BlueRock Therapeutics by Germany based Bayer AG which was valued at USD 1 billion. This represents an added important transaction by the Versant-formed companies.

As per credible sources, Versant considered the plan and commenced to build BlueRock in 2015 with opinion that stem cells had the potential to yield regenerative therapeutics based considering the fundamental advances achieved in cell differentiation, production and engineering.

Reportedly, the preliminary seed phase covered over a year allowing the required time to secure foundational technology from the recognized universities of Toronto and New York.

Speculation has it that in December 2016, BlueRock originated with USD 225 million in Series A round led by Versant and Bayer. Making use of this financing, the company extended its ranks with a commendable team including over more than 70 scientists at its R&D facility.

As per sources, Bayer has been claimed to acquire the shares in BlueRock for about USD 600 million, with about USD 240 million up front and up to USD 360 million preclinical and early clinical milestone payments.

Brad Bolzon, the Managing Director and chairman at Versant was reportedly quoted stating that the BlueRock acquisition strengthen the firms’ current approach to recognize the promising new discoveries happening in the field of science across the globe.

Jerel Davis, Managing Director, Versant and board director BlueRock was quoted stating that Versant has successfully established a Canadian presence to identify the unexploited sources of innovations in the emerging fields. The firm is looking forward for a global recognition with Bayer’s acquisition of BlueRock.

For the records, 1999 established Versant Ventures is a principal healthcare venture capital firm dedicated to helping excellent entrepreneurs build the next generation of great companies. The firm lays major emphasis on biotechnology companies that are currently discovering and evolving novel therapeutics.

Source credit: https://www.businesswire.com/news/home/20190808005234/en/Versant-Ventures-Announces-Acquisition-Cell-Therapy-Company

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

China unveils plans to reinforce stringent safety standards for EVs

China unveils plans to reinforce stringent safety standards for EVs

By Mateen Dalal

This news comes amid rising incidences of battery fires and breaks failures. China will require automakers to have a 24-hour emergency response system to address major accidents. China is planning to reinforce strict safety standards for electri...

Facebook testing new option for cross-posting content to Instagram

Facebook testing new option for cross-posting content to Instagram

By Mateen Dalal

Facebook, Inc is reportedly testing an option that will allow users to cross-post their photos, videos, and other posts on their Instagram. It already has the feature to let people cross-post their Instagram content to Facebook. This upcoming featur...

General Motors to recoup USD 1.9 Bn from LG spent on Bolt EV recall

General Motors to recoup USD 1.9 Bn from LG spent on Bolt EV recall

By Mateen Dalal

GM will recover almost all the costs from the recall of its Bolt EV models. Despite the EV battery manufacturing mishap from LG, the two companies will continue to work together. General Motors (GM) has agreed to recover around USD 1.9 billion f...